Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri
PharmaTalkRadio13 Jan 2023

Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri

Neoadjuvant (pre-surgical) immune checkpoint blockade may prevent cancer relapse and progression.This treatment approach is now FDA-approved for resectable triple-negative breast cancer, and hundreds of clinical trials in other cancers are ongoing.Surgical resection specimens collected after several weeks of neoadjuvant ICB offer vast opportunities for predictive biomarker discovery and understanding ICB response/resistance. Suzanne Topalian, MD, Associate Director / Professor of Surgery, Bloomberg~Kimmel Institute for Cancer Immunotherapy / Johns Hopkins University Learn more about the IO360° Summit at www.io360summit.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rss-nysgjerrige-norge
romkapsel
liberal-halvtime
rekommandert
jss
villmarksliv
dekodet-2
tomprat-med-gunnar-tjomlid
rss-paradigmepodden
vett-og-vitenskap-med-gaute-einevoll
fjellsportpodden
abels-tarn
sinnsyn
rss-rekommandert
rss-overskuddsliv
diagnose
nordnorsk-historie
rss-inn-til-kjernen-med-sunniva-rose